Andrea Marcellusi

Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study

D. Santini, E. Leo, S. Costa, 2011, Current medical research and opinion.

Economic burden of HPV9-related diseases: a real-world cost analysis from Italy

P. Bonanni, F. Mennini, A. Marcellusi, 2019, The European Journal of Health Economics.

Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country

P. Sciattella, M. Soro, R. E. Schmieder, 2015, European Journal of Health Economics.

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma

Andrea Marcellusi, J. Pöhlmann, M. Weller, 2024, Frontiers in Oncology.

For peer review only Governance of Preventive Health Intervention and On Time Verification of its Efficiency: the GIOVE study

L. Gitto, G. Favato, G. Cauzillo, 2011 .

Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

P. Bossi, F. Mennini, A. Marcellusi, 2019, Head & neck.

Impact of Chronic Coronary Artery Disease and Revascularization Strategy in Patients with Severe Aortic Stenosis Who Underwent Transcatheter Aortic Valve Implantation.

C. Trani, G. Tarantini, C. Fraccaro, 2023, The American journal of cardiology.

The economic burden of HCV-induced diseases in Italy. A probabilistic cost of illness model.

F. Mennini, A. Marcellusi, A. Capone, 2015, European review for medical and pharmacological sciences.

Analisi di impatto sul budget sanitario italiano di roxadustat per il trattamento dell’anemia da malattia renale cronica

Lucia Del Vecchio, P. Di Rienzo, Andrea Marcellusi, 2024, Global & regional health technology assessment.